Visalytics
Visalytics
approved EB-2 (NIW)

Postdoctoral Scholar

Translational Cancer Research · China · 2025-01-18

Processing Time
60 days
Decision Date
2025-01-18
Location
California
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to identify critical mechanisms of antiandrogen drug resistance to develop novel targeted therapies for advanced prostate cancer. This work involves validating novel compounds and uncovering therapeutic targets to improve clinical outcomes for oncology patients.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses drug resistance in oncology, which is a critical challenge with significant implications for national cancer care.

2 Well-positioned to Advance the Endeavor Met

The petitioner's Ph.D., publication record of 14 articles, 182 citations, and 39 peer reviews demonstrate the necessary expertise and influence.

3 On Balance, Beneficial to Waive Job Offer Met

The national benefits of the petitioner's continued research in prostate cancer treatment outweigh the need for a labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in pharmacology and toxicology and a record of 14 peer-reviewed journal articles with 182 citations. Additionally, the petitioner completed 39 peer reviews and submitted four expert recommendation letters, satisfying all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Judging Experience
Original Contributions

Similar Cases

Postdoctoral Researcher

Biotechnology · India

WeGreened EB-2 (NIW) approved
Missouri 49 days 2025-04-01
The petitioner proposes to identify novel therapeutic targets to improve personalized medicine and enhance treatment outcomes for cancer patients. Her work focuses on addressing drug resistance in oncology by integrating synthetic biology, protein engineering, and tumor signaling analysis to develop optimized drug delivery methods.
View Case

Postdoctoral Researcher

Biotechnology · Taiwan

WeGreened EB-2 (NIW) approved
Maryland 26 days 2025-06-02
The petitioner proposes to continue research in cancer biology, specifically exploring the molecular mechanisms behind tumor progression and drug resistance. This work focuses on identifying novel therapeutic targets to inform the development of advanced combination therapies and precision medicine paradigms. The intended impact is to improve patient survival rates by creating safer and more effective treatment options for cancers that have evolved resistance to conventional therapies.
View Case

Postdoctoral Researcher

Research and Development · Japan

WeGreened EB-2 (NIW) approved
Maryland 63 days 2022-04-25
The petitioner proposes to continue developing liquid-based, non-invasive biomarker identification and cancer treatment strategies to advance innovations in the care of prostate cancer patients. Her work focuses on the development of novel detection and treatment protocols for metastatic castration-resistant prostate cancer (mCRPC) to improve patient outcomes and quality of life.
View Case

Research Fellow

Biotechnology · China

WeGreened EB-2 (NIW) approved
Massachusetts 312 days 2025-04-10
The petitioner proposes to continue research into uncovering the genetic mechanisms that cause resistance to cancer therapies. Using state-of-the-art screening techniques, the work aims to accelerate the development of next-generation combination therapies to overcome tumor resistance. The endeavor focuses on exploring gene targets affecting immunotherapy response and examining the molecular behavior of oncogenic proteins.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-01-18.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 60 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist